Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports the creation of chiral building blocks essential for drug design, especially in treatments targeting viral infections and metabolic disorders. Commonly employed in research settings for optimizing synthetic routes and enhancing stereochemical control during active pharmaceutical ingredient (API) production.